Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.

NCT05182151 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT05182151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.
Lead sponsor
Medical University of South Carolina
Phase
Observational
Overall status
Terminated
Start date
July 29, 2022
Completion date
December 1, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apathy, parkinson disease